Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by TriumphSpitSixon Oct 15, 2020 12:39am

220 Views

Post# 31719344

RE:RE:RE:A Lottery Ticket

Pure tripe. Bash harder.

Blazesb wrote: I was long 254,000 shares average price of .38. Accumulated the position over two years. Unloaded all but 20,000--after the 'acetaminophin' fiasco--in the mid forties. Not much of a return for a two year commitment. Dan's 'timely' sales left a sour taste.

I like the hiring of Stern a lot. It implies that Antibe mgmt understands, however belatedly, that perhaps Dan is not the best person to make the case for the phase two data to potential licencing partners and/or acquirers.

I fear that as more time goes by potential catalysts--we all know what they are--are being baked into the share price rather than understood as the game changers we want them to be. Nasdaq listing--market yawns--official phase 3 announcement--yawn. Distribution deal with small country/small market--yawn.

Because if that's the case we're bag holders stuck with shares and no catalyst in sight until the release of phase 3 results one or more years from now.

I'll be closely watching the presentation at the upcoming conference. If it's just Dan spouting boiler plate, and not Dr. Wallace front and center, then i'll feel even better about my double in silver miners since i sold antibe than i already do.